Details for New Drug Application (NDA): 088250
✉ Email this page to a colleague
NDA 088250 describes ANUSOL HC, which is a drug marketed by Salix Pharms and is included in one NDA. It is available from one supplier. Additional details are available on the ANUSOL HC profile page.
The generic ingredient in ANUSOL HC is hydrocortisone. There are sixty-seven drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.
The generic ingredient in ANUSOL HC is hydrocortisone. There are sixty-seven drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the hydrocortisone profile page.
Summary for 088250
| Tradename: | ANUSOL HC |
| Applicant: | Salix Pharms |
| Ingredient: | hydrocortisone |
| Patents: | 0 |
Pharmacology for NDA: 088250
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 088250
Suppliers and Packaging for NDA: 088250
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ANUSOL HC | hydrocortisone | CREAM;TOPICAL | 088250 | ANDA | Salix Pharmaceuticals, Inc | 65649-401 | 65649-401-30 | 1 TUBE in 1 CARTON (65649-401-30) / 30 g in 1 TUBE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CREAM;TOPICAL | Strength | 2.5% | ||||
| Approval Date: | Jun 6, 1984 | TE: | AT | RLD: | No | ||||
Complete Access Available with Subscription
